Bay Area Reporter

Study suggests PEP-in-pocket is another HIV prevention option

Having antiretrovirals on hand to take as post-exposure prophylaxis after potential HIV exposure, an approach known as PEP-in-pocket, or PIP, is a feasible prevention option, especially for people who ...
Healio

PEP underutilized for HIV prevention, study suggests

Please provide your email address to receive an email when new articles are posted on . Roughly one-third of people eligible for HIV post-exposure prophylaxis did not receive a prescription. Fewer ...
Yahoo Finance

RION Announces Final Patient Enrolled in the Phase 2 Clinical Study for Purified Exosome Product™ (PEP™) in Diabetic Foot Ulcers

ROCHESTER, Minn., January 13, 2025--(BUSINESS WIRE)--RION, a clinical-stage regenerative medicine company at the forefront of exosome-based therapeutics, announced today that it has completed patient ...
Yahoo Finance

INTENT Biologics Receives FDA Agreement Granting a Full Waiver for its Pediatric Study Plan for PEP Biologic™ in Advanced Wound Care

ROCHESTER, Minn., January 21, 2026--(BUSINESS WIRE)--INTENT Biologics, a clinical-stage biotechnology company developing PEP Biologic as the first-in-class exosome-based biologic therapies for serious ...
Aidsmap

High HIV incidence from non-primary partners and low PEP and PrEP use seen in PARTNER study

With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...
MarketWatch

INTENT Biologics Receives FDA Agreement Granting a Full Waiver for its Pediatric Study Plan for PEP Biologic(TM) in Advanced Wound Care

INTENT Biologics, a clinical-stage biotechnology company developing PEP Biologic as the first-in-class exosome-based biologic therapies for serious conditions with significant unmet medical need, ...